凝血途径作为急性腹膜血瘤的决定因素 解析:从人类数据中获得的遗传证据
Qizhong Wu1, Tingting Xu2, Bo Tan2
1Department of Critical Care Medicine, Guangyuan Central Hospital, Guangyaun, Sichuan, China.
CNS neuroscience & therapeutics
|January 7, 2026
概括
影响血液凝固的遗传因素,如纤维素γ'和因子VIII和XI,可能会影响急性腹腔内血瘤的分辨率. 需要进一步的研究来证实这些发现在特定的患者队列.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
背景情况:
- 急性脑下血液瘤 (ASDH) 是一种严重的创伤性脑损伤并发症,死亡率高.
- 自发性血液瘤解脱对于功能恢复至关重要,但人们对其了解甚少.
- 凝血病在ASDH动态和解决中的作用仍然不确定.
研究的目的:
- 使用孟德尔随机化研究ASDH中凝血特征和血液瘤解脱之间的因果关系.
- 探索特定的凝血因子和纤维素原异型对血液瘤清除的影响.
主要方法:
- 采用了一个双样本的门德尔随机化研究设计.
- 从大型GWAS中使用了凝血因子 (纤维素γ',VIII,XI) 和血小板特征的遗传仪器.
- 脑内出血 (ICH) 易感性和中风后的功能性结果作为血液瘤解决的代理因缺乏ASDH特异性GWAS数据.
主要成果:
- 基因上较高的纤维素 γ'水平与血液瘤解脱的几率增加有关 (OR 1.25).
- 升高的VIII和XI因子水平与血液瘤解脱率降低有关 (OR分别为0.82和0.88).
- 使用中风后功能结果的二次分析显示了类似的趋势,但缺乏统计学意义.
结论:
- 遗传证据表明,涉及纤维素γ',XIII因子和XI因子的凝血途径可能会影响ASDH分辨率.
- 由于使用间接代理,这些发现产生了假设,并且需要在ASDH特定队列中进行验证.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
12.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Coagulation
9.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.6K
Introduction to Hemostasis
13.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.2K
Clot Retraction and Fibrinolysis
8.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.4K
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K


